Sljedeći

Auto Play

Clinical Trial for Advanced Bile Duct Cancer

0 Pogledi • 07/01/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play